CLINICAL PATHWAYS FOR ACUTE CARE IN TASMANIAN EMERGENCY DEPARTMENTS
With Associate Professor Viet Tran, Deputy Director of Emergency Medicine at Royal Hobart Hospital & Founding Director, Tasmanian Emergency Medicine Research Institute & Emergency Medicine Discipline Lead, University of Tasmania, Tasmania, Australia
RESEARCHER PROFILE
Filmed in Hobart, Australia | July 2025
Viet Tran is Associate Professor of Emergency Medicine at the University of Tasmania, Founding Director of the Tasmanian Emergency Medicine Research Institute, Deputy Director of Emergency Medicine at Royal Hobart Hospital, Chair of the Tasmanian Emergency Departments Network and Inaugural Co-Chair of the Tasmanian Health Senate.
A/Prof Tran also works at the coalface of healthcare as an Emergency Physician and continually advocates for excellence in patient care through education, research, quality and safety and health reform.
He has built Emergency Medicine Research in Tasmania from the ground up, which has culminated in the success of a AUD$3 million Australian Government Medical Research Futures Fund grant looking into the Implementation of Clinical Pathways for Acute Care in Tasmania project. Dr Tran is also the Emergency Medicine Discipline lead within the Tasmanian School of Medicine and has key roles to play within Emergency Medicine training. He feels privileged to be able to teach and mentor across the whole spectrum of becoming a doctor, from watching students grow into junior doctors, senior registrar and as fellow medical specialists.
Source: University of Tasmania website
-
Biostatistics in Clinical Trials
As a biostatistician working in research and clinical settings, Kate Francis plays a vital role in ensuring all projects adhere to best practice guidelines and are transparently reported. She has served as the lead statistician for the analysis of clinical trials across a broad range of subject areas, including neonatal resuscitation, BCG for allergy and infection, convulsive status epilepticus and her work has been published in the top journals such as The New England Journal of Medicine, JAMA, and The Lancet. Most recently she was awarded the 2025 Excellence in Trial Statistics Award for her work on the PLUSS trial.
-
Better biomarkers for predicting the incidence of having atherosclerosis and heart attack
Assoc Prof Bursill is a vascular biologist with interests and expertise in vascular inflammation, atherosclerosis and angiogenesis. She completed her PhD at The University of Adelaide in lipid metabolism then headed to Oxford University for five years to undergo a postdoctoral post in the Departments of Cardiovascular Medicine and Pathology. Her postdoctoral time triggered her interest in the mechanisms that cause atherosclerosis and in particular the role of small inflammatory proteins called chemokines.
-
Touched by bowel cancer and chasing science outcomes
Dr Josephine Wright is a Senior Research Fellow in the Gut Cancer group. She has been developing a translational network of labs, hospitals and clinics to enable validation of new approaches to prevent and treat colorectal and gastric cancer. Her key focus is studying human tumour organoids to better personalise therapy in cancer.
